Extraction and Determination of Cefazolin Sodium and Cefotaxime Sodium in Human Urine with a Weak Ion Exchange Monolithic Column

Development of a fluorescent probe for cefazolin detection based on solvent-based de-emulsification dispersive liquid-liquid microextraction of silver nanoparticles

A novel, simple, and rapid method has been developed for the fluorimetric determination of trace levels of cefazolin. The method is based on the synthesis of silver nanoparticles (AgNPs) as fluorescent probes using resorcinol as a reducing and capping agent and then their extraction into the 1-octanol by a highly efficient solvent-based de-emulsification dispersive liquid-liquid microextraction technique. The interaction of cefazolin with silver affected the fluorescence intensity of AgNPs in the organic phase that creates a micro-probe fluorimetric detection of this antibiotic at excitation/emission wavelengths of 410/527 nm. Under the established optimum conditions, the linear analytical range was from 0.80 to 12.00 ng mL^-1 of cefazolin with a detection limit of 0.55 ng mL^-1. The relative standard deviation for ten replicate measurements of 2 and 10 ng mL^-1 of cefazolin was 4.18 and 1.88%, respectively. The suggested method was successfully applied to the determination of cefazolin in pharmaceutical formulation, human urine and plasma.

Perovskite quantum dots as a chemiluminescence platform for highly sensitive assay of cefazolin

This paper reports on a chemiluminescence (CL) probe consist of CsPbBr₃ quantum dots (QDs) in organic phase together with Fe(II) and K₂S₂O₈ in aqueous medium for the highly selective and sensitive determination of the antibiotic, cefazolin (CFZ). The CsPbBr₃perovskite QDs prepared by the ligand assisted reprecipitation method, exhibit a narrow fluorescence at 533 nm under 460 nm excitation with a high quantum yield (42 %). The Fe(II) - S₂O₈^2- as an ultra-weak CL system is converted to a rather strong CL sensing platform in the presence of organic-phase CsPbBr₃ QDs. It was observed that CFZ exerts an enhancement effect on the CL signal of the designed probe in the linear range of 25 - 300 nM, with a low limit of detection (9.6 nM). The introduced sensor has broad application prospects in biosensing, food detection, and other fields with recovery ranging from 94 to 106 %.

Nano-optosensor based on titanium dioxide and graphene quantum dots composited with specific polymer for cefazolin detection

An optosensor using nanocomposite probes was fabricated for the detection of trace cefazolin. The nanoprobes utilized the high affinity of titanium dioxide, the good optical properties of graphene quantum dots and the good selectivity of molecularly imprinted polymer. The integration of these materials produced a rapid, highly sensitive optosensor with excellent selectivity for cefazolin detection. The fluorescence intensity of the nanocomposite probes was quenched when cefazolin re-bound with the imprinted recognition cavities of the nanoprobes. The fabricated nanoprobe exhibited a good linearity for cefazolin from 0.10 to 10.0 μg L^-1 with a limit of detection of 0.10 μg L^-1. The imprinting factor of the nanoprobe was 10.6 and selectivity for cefazolin was not affected by the analogue structures of cephalexin, cefatriaxone, cephradine, cefaperazone and ceftazidime. This nano-optosensor probe successfully detected cefazolin in milk and recoveries were between 85.0 and 97.4 % with RSDs less than 5.0 %. The results of analysis with nano-optosensor were in good agreement with HPLC analysis. The fabrication strategy of the nanocomposite probe can be modified for the measurement of other toxic compounds.

Recent Trends in Fast Liquid Chromatography for Pharmaceutical Analysis

Background:

Liquid chromatography is the workhorse of analytical laboratories of pharmaceutical companies for analysis of bulk drug materials, intermediates, drug products, impurities and degradation products. This efficient technique is impeded by its long and tedious analysis procedures. Continuous efforts of scientists to reduce the analysis time resulted in the development of three different approaches namely, HTLC, chromatography using monolithic columns and UHPLC.

Methods:

Modern column technology and advances in chromatographic stationary phase including silica-based monolithic columns and reduction in particle and column size (UHPLC) have not only revolutionized the separation power of chromatographic analysis but also have remarkably reduced the analysis time. Automated ultra high-performance chromatographic systems equipped with state-ofthe- art software and detection systems have now spawned a new field of analysis, termed as Fast Liquid Chromatography (FLC). The chromatographic approaches that can be included in FLC are hightemperature liquid chromatography, chromatography using monolithic column, and ultrahigh performance liquid chromatography.

Results:

This review summarizes the progress of FLC in pharmaceutical analysis during the period from year 2008 to 2017 focusing on detecting pharmaceutical drugs in various matrices, characterizing active compounds of natural products, and drug metabolites. High temperature, change in the mobile phase, use of monolithic columns, new non-porous, semi-porous and fully porous reduced particle size of/less than 3μm packed columns technology with high-pressure pumps have been extensively studied and successively applied to real samples. These factors revolutionized the fast high-performance separations.

Conclusion:

Taking into account the recent development in fast liquid chromatography approaches, future trends can be clearly predicated. UHPLC must be the most popular approach followed by the use of monolithic columns. Use of high temperatures during analysis is not a feasible approach especially for pharmaceutical analysis due to thermosensitive nature of analytes.